Valerie Delecroix - Publications

Improving real-world evaluation of patient- and physician-reported tolerability: niraparib for recurrent ovarian cancer (NiQoLe).

Journal: JNCI cancer spectrum

Published: July 14, 2024

Quality of advanced ovarian cancer surgery: A French assessment of ESGO quality indicators.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: May 14, 2020

Long-term fatigue and quality of life among epithelial ovarian cancer survivors: a GINECO case/control VIVROVAIRE I study.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: March 10, 2019

Long survival of patients with metastatic clear cell renal cell carcinoma. Results of real life study of 344 patients.

Journal: International journal of cancer

Published: January 16, 2019

Clinical validation of a prognostic tool in a population of outpatients treated for incurable cancer undergoing anticancer therapy: PRONOPALL study.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: October 20, 2016

Constitutional variants are not associated with HER2-positive breast cancer: results from the SIGNAL/PHARE clinical cohort.

Journal: NPJ breast cancer

Published: August 28, 2016

Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes.

Journal: Breast cancer research : BCR

Published: May 24, 2016

GWAS in the SIGNAL/PHARE clinical cohort restricts the association between the FGFR2 locus and estrogen receptor status to HER2-negative breast cancer patients.

Journal: Oncotarget

Published: April 12, 2016

Telomere length is a prognostic biomarker in elderly advanced ovarian cancer patients: a multicenter GINECO study.

Journal: Aging

Published: December 07, 2015